In particular, the numbers of CD19+ circulating B cells and tissue‐resident CD19+CD138+ plasma cells were significantly reduced by mRNab‐LNPs in MRL/lpr lupus and RA mice. The gene discussed is CD19; the disease is rheumatoid arthritis.